The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Glutathione, oxidative stress and neurodegeneration
Abstract
There is significant evidence that the pathogenesis of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Friedreich's ataxia and amyotrophic lateral sclerosis, may involve the generation of reactive oxygen species and mitochondrial dysfunction. Here, we review the evidence for a disturbance of glutathione homeostasis that may either lead to or result from oxidative stress in neurodegenerative disorders. Glutathione is an important intracellular antioxidant that protects against a variety of different antioxidant species. An important role for glutathione was proposed for the pathogenesis of Parkinson's disease, because a decrease in total glutathione concentrations in the substantia nigra has been observed in preclinical stages, at a time at which other biochemical changes are not yet detectable. Because glutathione does not cross the blood–brain barrier other treatment options to increase brain concentrations of glutathione including glutathione analogs, mimetics or precursors are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress, Caloric Restriction, and Aging
Sohal, R. S., & Weindruch, R. (1996) · Science · doi:10.1126/science.273.5271.59 · Cited by 3,131
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“Strong evidence that oxidative stress is involved in the pathogenesis of AD comes from a clinical study showing that oral vitamin E intake delayed progression in patients with moderately severe impairment from AD [47].”
BackgroundBcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111
Free Radicals and Antioxidants in the Year 2000: A Historical Look to the Future
GUTTERIDGE, J. M. C., & HALLIWELL, B. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06182.x · Cited by 1,009
Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis
Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808
Dringen, R., Gutterer, J. M., & Hirrlinger, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01597.x · Cited by 760
Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · cited 1×
“Direct evidence for age-dependent increase in oxidative damage to mitochondrial DNA comes from measurements of 8-hydroxy-2 0-deoxyguanosine (8OH2 0dG), which is an oxidized form of deoxyguanosine that occurs following attack by a variety of free radicals [12].”
BackgroundParkinson's disease: A disorder due to nigral glutathione deficiency?
Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753
Bains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 717
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
Beal, M. F., Ferrante, R. J., Browne, S. E., Matthews, R. T., Kowall, N. W., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410420416 · Cited by 598
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 590
Dringen, R., Pfeiffer, B., & Hamprecht, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00562.1999 · Cited by 589 · cited 1×
“Neurons can utilize either g-glutamylcysteine or cysteinylglycine for the synthesis of GSH [75].”
BackgroundSchizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · cited 1×
“A 27% decrease in GSH has been reported in the CSF of drug-free schizophrenic patients [68].”
BackgroundAdvances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds
Tipton, K. F., & Singer, T. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13610.x · Cited by 539
A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion
Li, Y., Maher, P., & Schubert, D. (1997) · Neuron · doi:10.1016/s0896-6273(00)80953-8 · Cited by 514
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513 · cited 2×
“A role of oxidative stress in AD is further supported by increased levels of thiobarbituric acid-reactive substances, a measure of lipid peroxidation [48,49].”
BackgroundGlutathione deficiency leads to mitochondrial damage in brain.
Jain, A., Mårtensson, J., Stole, E., Auld, P. A., & Meister, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1913 · Cited by 428
Oxidative damage in neurodegenerative disease
Jenner, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92347-7 · Cited by 418
Dopamine turnover and glutathione oxidation: implications for Parkinson disease.
Spina, M. B., & Cohen, G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1398 · Cited by 395
Pedersen, W. A., Fu, W., Keller, J. N., Markesbery, W. R., Appel, S., Smith, R. G., Kasarskis, E., & Mattson, M. P. (1998) · Annals of Neurology · doi:10.1002/ana.410440518 · Cited by 391
Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · cited 1×
“If cysteine is not used for the synthesis of glutathione, it may react with the dopamine-o-quinone, which results from nonenzymatic oxidation of dopamine, to form 5-S-cysteinyldopamine [39].”
BackgroundPerry, T. L., & Yong, V. W. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90320-4 · Cited by 361
Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
Brown, R. H. (1995) · Cell · doi:10.1016/0092-8674(95)90346-1 · Cited by 352
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S., Jenner, P., & Marsden, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
Rapid and Specific Efflux of Reduced Glutathione during Apoptosis Induced by Anti-Fas/APO-1 Antibody
van den Dobbelsteen, D. J., Nobel, C. S. I., Schlegel, J., Cotgreave, I. A., Orrenius, S., & Slater, A. F. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15420 · Cited by 343
Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. M., Wells, F. R., Daniel, S. E., Lees, A. J., Schapira, A. H. V., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350107 · Cited by 317
Parkinson's disease, pesticides, and glutathione transferase polymorphisms
Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., & Couteur, D. G. L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03453-9 · Cited by 314
Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis
Macho, A., Hirsch, T., Marzo, I., Marchetti, P., Dallaporta, B., Susin, S. A., Zamzami, N., & Kroemer, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4612 · Cited by 299
Glutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296
Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., & Cleveland, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7606 · Cited by 288
Self-citationDecreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275
Smith, R. G., Henry, Y. K., Mattson, M. P., & Appel, S. H. (1998) · Annals of Neurology · doi:10.1002/ana.410440419 · Cited by 257
L-Cysteine, a Bicarbonate-Sensitive Endogenous Excitotoxin
Olney, J. W., Zorumski, C., Price, M. T., & Labruyere, J. (1990) · Science · doi:10.1126/science.2185543 · Cited by 257
Sato, N., Iwata, S., Nakamura, K., Hori, T., Mori, K., & Yodoi, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3194 · Cited by 235
Heales, R., Davies, S. E. C., Bates, T. E., & Clark, J. B. (1995) · Neurochemical Research · doi:10.1007/bf00995149 · Cited by 188
Wüllner, U., Seyfried, J., Groscurth, P., Beinroth, S., Winter, S., Gleichmann, M., Heneka, M., Löschmann, P.-A., Schulz, J. B., Weller, M., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01228-7 · Cited by 183
Self-citationReduced and oxidized glutathione in human and monkey brain
Slivka, A., Spina, M. B., & Cohen, G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90061-9 · Cited by 162
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
Bloem, B. R., Irwin, I., Buruma, O. J. S., Haan, J., Roos, R. A. C., Tetrud, J. W., & Langston, J. W. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90225-c · Cited by 160
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones
Wüllner, U., Löschmann, P. A., Schulz, J. B., Schmid, A., Dringen, R., Eblen, F., Turski, L., & Klockgether, T. (1996) · Neuroreport · doi:10.1097/00001756-199603220-00018 · Cited by 152
Self-citationAksenov, M. Y., Tucker, H. M., Nair, P., Aksenova, M. V., Butterfield, D. A., Estus, S., & Markesbery, W. R. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:2:151 · Cited by 139
McNaught, K. S. P., & Jenner, P. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732469.x · Cited by 132
Zhang, F., & Dryhurst, G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00034a006 · Cited by 129
Perry, T. L., Yong, V. W., Bergeron, C., Hansen, S., & Jones, K. L. (1987) · Annals of Neurology · doi:10.1002/ana.410210403 · Cited by 121
Beaver, J., & Waring, P. (1995) · PubMed · Cited by 121
Philbert, M. A., Beiswanger, C. M., Waters, D. K., Reuhl, K. R., & Lowndes, H. E. (1991) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(91)90204-r · Cited by 120
Antisera to Glutathione: Characterization and Immunocytochemical Application to the Rat Cerebellum
Hjelle, O. P., Chaudhry, F. A., & Ottersen, O. P. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00990.x · Cited by 110
Li, H., & Dryhurst, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041530.x · Cited by 109
Dringen, R., & Hamprecht, B. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00894-5 · Cited by 108
Przedborski, S., Donaldson, D. M., Jakowec, M. W., Kish, S. J., Guttman, M., Rosoklija, G. B., & Hays, A. P. (1996) · Annals of Neurology · doi:10.1002/ana.410390204 · Cited by 97
Mitochondrial dysfunction in movement disorders
Schulz, J. B., & Beal, M. F. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00010 · Cited by 92
Self-citationPileblad, E., Magnusson, T., & Fornstedt, B. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb02550.x · Cited by 87
Bojes, H. K., Datta, K., Xu, J., Chin, A. J., Simonian, P. L., Núñez, G., & Kehrer, J. P. (1997) · Biochemical Journal · doi:10.1042/bj3250315 · Cited by 86
Bockstaele, E. J. V., Chan, J., & Pickel, V. M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960801)45:3<276::aid-jnr9>3.0.co;2-a · Cited by 83
Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration
Toffa, S., Kunikowska, G., Zeng, B. ‐., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271295 · Cited by 83
Lindenau, J., Noack, H., Asayama, K., & Wolf, G. L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199810)24:2<252::aid-glia10>3.0.co;2-z · Cited by 83
Self-citationShen, X.-M., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960008f · Cited by 76
Seyfried, J., Soldner, F., Schulz, J. B., Klockgether, T., Kovar, K. ‐., & Wüllner, U. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00107-x · Cited by 75
Self-citationReduction of Lower Motor Neuron Degeneration inwobblerMice byN-Acetyl-l-Cysteine
Henderson, J. T., Javaheri, M., Kopko, S., & Roder, J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-23-07574.1996 · Cited by 73
Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation.
Apostolski, S., Marinkovic, Z., Nikolić, A., Blagojević, D. P., Spasić, M. B., & Michelson, A. M. (1998) · PubMed · Cited by 59
Przedborski, S., Donaldson, D. M., Murphy, P. L., et al. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0008 · Cited by 56
Glial Cells Mediate Toxicity in Glutathione‐Depleted Mesencephalic Cultures
Mytilineou, C., Leonardi, E. T. K., Kramer, B. C., Jamindar, T. M., & Olanow, C. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730112.x · Cited by 51
Lanius, R. A., Krieger, C., Wagey, R. T. E., & Shaw, C. A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90236-e · Cited by 48
Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells
Seyfried, J., Soldner, F., Kunz, W. S., Schulz, J. B., Klockgether, T., Kovar, K. A., & Wüllner, U. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00156-4 · Cited by 48
Self-citationShaw, I. C., Fitzmaurice, P. S., Mitchell, J. D., & Lynch, P. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0047 · Cited by 40
Pileblad, E., & Magnusson, T. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90121-x · Cited by 40
Moumen, R., Nouvelot, A., Duval, D., Lechevaliera, B., & Viadera, F. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00109-3 · Cited by 36
Protective actions of YM737, a new glutathione analog, against cerebral ischemia in rats.
Yamamoto, M., Sakamoto, N., Iwai, A., Yatsugi, S., Hidaka, K., Noguchi, K., & Yuasa, T. (1993) · PubMed · Cited by 24
Seaton, T. A., Jenner, P. G., & MARSDEN, C. D. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271243 · Cited by 20
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
Chen, X., Pradhan, T., Wang, F., Kim, J. S., & Yoon, J. (2012) · Chemical Reviews · doi:10.1021/cr200201z · Cited by 1,984
Astrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions
Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266
The molecular basis of working mechanism of natural polyphenolic antioxidants
Leopoldini, M., Russo, N., & Toscano, M. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.08.012 · Cited by 1,266
Metadata
- Authors
- Schulz, J. B., Lindenau, J., Seyfried, J., & Dichgans, J.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 267
- Issue
- 16
- Pages
- 4904-4911
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2144361706
- Cited by
- 1,213
- References
- 73
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.